Glaucoma Treatment MarketThe global glaucoma treatment market, valued at USD 5.7 billion in 2022, is projected to grow at a CAGR of 3.18% during the forecast period, reaching an estimated USD 8.0 ...
They are prescribed to treat high BP, arrhythmia, angina, heart attack, migraine, glaucoma and even in thyroid problems. HIV patients taking beta blockers had 90 per cent higher risk of ...
A doctor may also prescribe them for other reasons, such as migraine, overactive thyroid, or glaucoma in your eyes. You can read more here about beta-blockers. Foods and beverages that may ...
Textbook of ophthalmology, vol 7, Glaucoma. London: Mosby, 1994. Levobunolol Study Group. Levobunolol: a beta adrenoreceptor antagonist effective in the long term treatment of glaucoma.